Stanford Career Development in Vascular Medicine

斯坦福血管医学职业发展

基本信息

  • 批准号:
    8324232
  • 负责人:
  • 金额:
    $ 52.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Vascular disease is the leading cause of morbidity and mortality in the United States. There is a public health need for increased transfer of knowledge between the various disciplines that constitute this research field, and accelerated application of the basic information to clinical practice. The Stanford program addresses with a multidisciplinary program and faculty performing scientific and clinical work related directly to Vascular Medicine including cardiovascular and pulmonary medicine, endocrinology, hematology, nephrology, immunology, epidemiology and clinical trials design, cell and molecular biology, developmental and stem cell biology, tissue and mechanical engineering, physics and computational modeling, genetics/genomics,proteomics, physiology and molecular pharmacology. This proposal is designed to address the educational and clinical needs in the emerging specialty of Vascular Medicine. The program will produce clinician investigators with a deep fund of knowledge regarding vascular medicine, and a high level of proficiency in clinical research. This new breed of investigators will apply cutting edge technology to clinically relevant questions in vascular medicine, and they will be able to train the next generation of vascular internists. Our Specific aims are to: 1) Develop, institute and annually evaluate a one year core clinical training program that confers competency in the management of arterial, venous and lymphatic diseases and associated disorders; 2) Formulate, initiate and annually update a didactic training program in clinical research emphasizing clinical trial design, biostatistics and bioinformatics, genomics and proteomics, regulatory affairs, and responsible conduct of research; 3) Provide a clinical research experience guided by an experienced Mentor, facilitated by a cohort of collaborative Co-mentors, and focused on a clinical research project. Other elements include exposure to trial design, interaction with and direct participation on the Institutional Review Board, database management and analysis, manuscript preparation, and grant writing. Lay description: Diseases of the arteries and veins cause most of the hospitalizations and deaths in the United States. Stanford University proposes a comprehensive educational program that will train a new breed of doctors that can recognize and treat these diseases, develop new therapies, and train young doctors in the care of people with vessel disease. (End of Abstract).
描述(由申请人提供): 血管疾病是美国发病率和死亡率的主要原因。有一个公共卫生需要增加知识的各个学科之间的转移,构成这个研究领域,并加速应用的基本信息的临床实践。该斯坦福大学计划地址与多学科计划和教师进行直接相关的血管医学,包括心血管和肺医学,内分泌学,血液学,肾脏学,免疫学,流行病学和临床试验设计,细胞和分子生物学,发育和干细胞生物学,组织和机械工程,物理和计算建模,遗传学/基因组学,蛋白质组学,生理学和分子药理学。该提案旨在满足血管医学新兴专业的教育和临床需求。该计划将产生临床研究人员与血管医学知识的深厚基础,并在临床研究的熟练程度高。这种新一代的研究人员将把尖端技术应用于血管医学的临床相关问题,他们将能够培养下一代血管内科医生。 我们的具体目标是:1)制定,制定和每年评估一年的核心临床培训计划,赋予动脉,静脉和淋巴疾病及相关疾病的管理能力; 2)制定,启动和每年更新临床研究教学培训计划,强调临床试验设计,生物统计学和生物信息学,基因组学和蛋白质组学,法规事务,以及负责任的研究行为; 3)提供由经验丰富的导师指导的临床研究经验,由一群合作的共同导师促进,并专注于临床研究项目。其他要素包括接触试验设计,与机构审查委员会的互动和直接参与,数据库管理和分析,手稿准备和赠款写作。通俗描述:在美国,动脉和静脉疾病是导致住院和死亡的主要原因。斯坦福大学提出了一项综合教育计划,该计划将培养一批能够识别和治疗这些疾病的新一代医生,开发新的疗法,并培训年轻医生护理血管疾病患者。(End抽象)。

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Clinical trials of adult stem cell therapy for peripheral artery disease.
成体干细胞治疗外周动脉疾病的临床试验。
Assessing endothelial vasodilator function with the Endo-PAT 2000.
The genome sequence of the colonial chordate, Botryllus schlosseri.
  • DOI:
    10.7554/elife.00569
  • 发表时间:
    2013-07-02
  • 期刊:
  • 影响因子:
    7.7
  • 作者:
    Voskoboynik A;Neff NF;Sahoo D;Newman AM;Pushkarev D;Koh W;Passarelli B;Fan HC;Mantalas GL;Palmeri KJ;Ishizuka KJ;Gissi C;Griggio F;Ben-Shlomo R;Corey DM;Penland L;White RA 3rd;Weissman IL;Quake SR
  • 通讯作者:
    Quake SR
Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease.
  • DOI:
    10.1161/atvbaha.111.230938
  • 发表时间:
    2011-11
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Rufaihah AJ;Huang NF;Jamé S;Lee JC;Nguyen HN;Byers B;De A;Okogbaa J;Rollins M;Reijo-Pera R;Gambhir SS;Cooke JP
  • 通讯作者:
    Cooke JP
Lansoprazole worsens asthma control in poor metabolizers: is nitric oxide involved?
兰索拉唑会恶化代谢不良者的哮喘控制:是否涉及一氧化氮?
  • DOI:
    10.1513/annalsats.201504-238le
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    8.3
  • 作者:
    Sukhovershin,RomanA;Ghebremariam,YohannesT;Cooke,JohnP
  • 通讯作者:
    Cooke,JohnP
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RONALD L DALMAN其他文献

RONALD L DALMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RONALD L DALMAN', 18)}}的其他基金

The LIMIting AAA with meTformin (LIMIT) Trial
使用二甲双胍限制 AAA (LIMIT) 试验
  • 批准号:
    10054902
  • 财政年份:
    2020
  • 资助金额:
    $ 52.16万
  • 项目类别:
The LIMIting AAA with meTformin (LIMIT) Trial
使用二甲双胍限制 AAA (LIMIT) 试验
  • 批准号:
    10274809
  • 财政年份:
    2020
  • 资助金额:
    $ 52.16万
  • 项目类别:
The LIMIting AAA with meTformin (LIMIT) Trial
使用二甲双胍限制 AAA (LIMIT) 试验
  • 批准号:
    10650132
  • 财政年份:
    2020
  • 资助金额:
    $ 52.16万
  • 项目类别:
Mechanisms and Significance of Angiogenesis in AAA Disease
AAA 疾病中血管生成的机制和意义
  • 批准号:
    8228228
  • 财政年份:
    2012
  • 资助金额:
    $ 52.16万
  • 项目类别:
Mechanisms and Significance of Angiogenesis in AAA Disease
AAA 疾病中血管生成的机制和意义
  • 批准号:
    8403798
  • 财政年份:
    2012
  • 资助金额:
    $ 52.16万
  • 项目类别:
Critical Role of Inflammatory Macrophages in AAA Pathogenesis
炎症巨噬细胞在 AAA 发病机制中的关键作用
  • 批准号:
    8179456
  • 财政年份:
    2011
  • 资助金额:
    $ 52.16万
  • 项目类别:
Critical Role of Inflammatory Macrophages in AAA Pathogenesis
炎症巨噬细胞在 AAA 发病机制中的关键作用
  • 批准号:
    8312534
  • 财政年份:
    2011
  • 资助金额:
    $ 52.16万
  • 项目类别:
Mechanisms in Innovation in Vascular Disease
血管疾病的创新机制
  • 批准号:
    8488467
  • 财政年份:
    2010
  • 资助金额:
    $ 52.16万
  • 项目类别:
Mechanisms in Innovation in Vascular Disease
血管疾病的创新机制
  • 批准号:
    8699255
  • 财政年份:
    2010
  • 资助金额:
    $ 52.16万
  • 项目类别:
2008 Stanford AAA Summit: Strategies for Multidisciplinary Research
2008 年斯坦福 AAA 峰会:多学科研究策略
  • 批准号:
    7614944
  • 财政年份:
    2008
  • 资助金额:
    $ 52.16万
  • 项目类别:

相似海外基金

Analysis of spatiotemporal involvement of retinoic acid in pharyngeal arch arteries
视黄酸对咽弓动脉的时空影响分析
  • 批准号:
    22KJ2601
  • 财政年份:
    2023
  • 资助金额:
    $ 52.16万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Molecular identification of the oxygen sensor(s) in the fetal ductus arteriosus and pulmonary artery: an integrated multiomic comparison of mitochondria in vital fetal arteries with opposing oxygen responses
胎儿动脉导管和肺动脉中氧传感器的分子识别:对胎儿重要动脉中具有相反氧反应的线粒体进行综合多组学比较
  • 批准号:
    462691
  • 财政年份:
    2022
  • 资助金额:
    $ 52.16万
  • 项目类别:
    Operating Grants
Understanding the regulatory control of complex blood flow in conduit arteries and veins
了解导管动脉和静脉中复杂血流的调节控制
  • 批准号:
    RGPIN-2021-02563
  • 财政年份:
    2022
  • 资助金额:
    $ 52.16万
  • 项目类别:
    Discovery Grants Program - Individual
Fetal cerebral arteries and prenatal alcohol exposure
胎儿脑动脉和产前酒精暴露
  • 批准号:
    10337722
  • 财政年份:
    2022
  • 资助金额:
    $ 52.16万
  • 项目类别:
Fetal cerebral arteries and prenatal alcohol exposure
胎儿脑动脉和产前酒精暴露
  • 批准号:
    10590708
  • 财政年份:
    2022
  • 资助金额:
    $ 52.16万
  • 项目类别:
Pregnenolone constricts cerebral vascular arteries through the direct modulation of BK ion channels
孕烯醇酮通过直接调节 BK 离子通道收缩脑血管动脉
  • 批准号:
    10441131
  • 财政年份:
    2021
  • 资助金额:
    $ 52.16万
  • 项目类别:
Understanding the regulatory control of complex blood flow in conduit arteries and veins
了解导管动脉和静脉中复杂血流的调节控制
  • 批准号:
    DGECR-2021-00028
  • 财政年份:
    2021
  • 资助金额:
    $ 52.16万
  • 项目类别:
    Discovery Launch Supplement
Association of brain temperature increase and cerebrospinal fluid dynamics in chronic brain ischemia due to main trunk occlusion of cerebral arteries
脑动脉主干闭塞所致慢性脑缺血脑温度升高与脑脊液动力学的关系
  • 批准号:
    21K09108
  • 财政年份:
    2021
  • 资助金额:
    $ 52.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studying guinea pig development to discover how natural collateral arteries form
研究豚鼠的发育以发现自然侧支动脉是如何形成的
  • 批准号:
    10195510
  • 财政年份:
    2021
  • 资助金额:
    $ 52.16万
  • 项目类别:
Studying guinea pig development to discover how natural collateral arteries form
研究豚鼠的发育以发现自然侧支动脉是如何形成的
  • 批准号:
    10405492
  • 财政年份:
    2021
  • 资助金额:
    $ 52.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了